| In vivo imaging of synaptic loss in Alzheimer’s disease with [18F] UCB-H positron emission tomography C Bastin, MA Bahri, F Meyer, M Manard, E Delhaye, A Plenevaux, ... European Journal of Nuclear Medicine and Molecular Imaging 47 (2), 390-402, 2020 | 111 | 2020 |
| Syntheses, Radiolabelings, and in Vitro Evaluations of Fluorinated PET Radioligands of 5-HT6 Serotoninergic Receptors J Colomb, G Becker, S Fieux, L Zimmer, T Billard Journal of medicinal chemistry 57 (9), 3884-3890, 2014 | 67 | 2014 |
| Measuring brain synaptic vesicle protein 2A with positron emission tomography and [18F] UCB-H MA Bahri, A Plenevaux, J Aerts, C Bastin, G Becker, J Mercier, A Valade, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 3 (4 …, 2017 | 63 | 2017 |
| Selective serotonin 5-HT 1A receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study G Becker, R Bolbos, N Costes, J Redouté, A Newman-Tancredi, L Zimmer Scientific reports 6 (1), 1-12, 2016 | 60 | 2016 |
| Enabling efficient positron emission tomography (PET) imaging of synaptic vesicle glycoprotein 2A (SV2A) with a robust and one-step radiosynthesis of a highly potent 18F … C Warnier, C Lemaire, G Becker, G Zaragoza, F Giacomelli, J Aerts, ... Journal of medicinal chemistry 59 (19), 8955-8966, 2016 | 52 | 2016 |
| Have (R)-[11C] PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies F Chauveau, G Becker, H Boutin European Journal of Nuclear Medicine and Molecular Imaging, 1-20, 2021 | 43 | 2021 |
| Quantitative longitudinal imaging of activated microglia as a marker of inflammation in the pilocarpine rat model of epilepsy using [11C]-(R)-PK11195 PET and MRI J Yankam Njiwa, N Costes, C Bouillot, S Bouvard, S Fieux, G Becker, ... Journal of Cerebral Blood Flow & Metabolism 37 (4), 1251-1263, 2017 | 39 | 2017 |
| Clinical imaging of the penumbra in ischemic stroke: From the concept to the era of mechanical thrombectomy L Chalet, T Boutelier, T Christen, D Raguenes, J Debatisse, OF Eker, ... Frontiers in Cardiovascular Medicine 9, 2022 | 35 | 2022 |
| The Rise of Synaptic Density PET Imaging G Becker, S Dammicco, MA Bahri, E Salmon Molecules 25 (10), 2303, 2020 | 34 | 2020 |
| Pharmacokinetic Characterization of [18F]UCB-H PET Radiopharmaceutical in the Rat Brain G Becker, C Warnier, ME Serrano, MA Bahri, J Mercier, C Lemaire, ... Molecular Pharmaceutics 14 (8), 2719-2725, 2017 | 32 | 2017 |
| Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging L Lemoine, G Becker, B Vacher, T Billard, S Lancelot, ... Journal of Nuclear Medicine 53 (6), 969-976, 2012 | 32 | 2012 |
| Nanofitin as a new molecular-imaging agent for the diagnosis of epidermal growth factor receptor over-expressing tumors M Goux, G Becker, H Gorré, S Dammicco, A Desselle, D Egrise, N Leroi, ... Bioconjugate chemistry 28 (9), 2361-2371, 2017 | 31 | 2017 |
| The Severe Deficiency of the Somatotrope GH-Releasing Hormone/Growth Hormone/Insulin-Like Growth Factor 1 Axis of Ghrh−/− Mice Is Associated With an Important Splenic Atrophy … G Bodart, K Farhat, C Renard-Charlet, G Becker, A Plenevaux, R Salvatori, ... Frontiers in endocrinology 9, 296, 2018 | 26 | 2018 |
| Comparative assessment of 6‐[18F]fluoro‐L‐m‐tyrosine and 6‐[18F]fluoro‐L‐dopa to evaluate dopaminergic presynaptic integrity in a Parkinson's disease rat … G Becker, MA Bahri, A Michel, F Hustadt, G Garraux, A Luxen, C Lemaire, ... Journal of Neurochemistry 141 (4), 626-635, 2017 | 25 | 2017 |
| Radiolabelling of lipid-based nanocarriers with fluorine-18 for in vivo tracking by PET S Nagachinta, G Becker, S Dammicco, ME Serrano, N Leroi, MA Bahri, ... Colloids and Surfaces B: Biointerfaces 188, 110793, 2020 | 24 | 2020 |
| A Postmortem Study to Compare Agonist and Antagonist 5‐HT1A Receptor‐binding Sites in Alzheimer's Disease G Becker, N Streichenberger, T Billard, A Newman‐Tancredi, L Zimmer CNS neuroscience & therapeutics 20 (10), 930-934, 2014 | 24 | 2014 |
| Synthesis and pharmacological evaluation of a new series of radiolabeled ligands for 5-HT7 receptor PET neuroimaging J Colomb, G Becker, E Forcellini, S Meyer, L Buisson, L Zimmer, T Billard Nuclear Medicine and Biology 41 (4), 330-337, 2014 | 23 | 2014 |
| Exploring with [18 F] UCB-H the in vivo Variations in SV2A Expression through the Kainic Acid Rat Model of Temporal Lobe Epilepsy ME Serrano, MA Bahri, G Becker, A Seret, C Germonpré, C Lemaire, ... Molecular imaging and biology, 1-11, 2020 | 22 | 2020 |
| Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging G Becker, J Colomb, V Sgambato-Faure, L Tremblay, T Billard, L Zimmer European journal of nuclear medicine and molecular imaging 42 (3), 495-502, 2015 | 21 | 2015 |
| Development and validation of a new mouse model to investigate the role of SV2A in epilepsy C Menten-Dedoyart, ME Serrano Navacerrada, O Bartholome, ... PloS one 11 (11), e0166525, 2016 | 19 | 2016 |
